Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications.
Trichomonas vaginalis is an underestimated sexually transmitted infection (STI) associated with numerous clinical sequelae. The true prevalence and clinical impact of trichomoniasis are unknown, as current methods of detection exhibit poor sensitivity compared to molecular amplification methods. Limited data exist comparing the BD Affirm VPIII hybridization assay to the Gen-Probe Aptima T. vaginalis (ATV) transcription-mediated amplification (TMA) assay for detection of T. vaginalis. In this study, specimens from 766 patients were evaluated. Specimens were retrieved consecutively from patients with vaginal complaints and/or with histories suggestive of STI. Study inclusion was dependent upon the request for and collection of both a vaginal swab for Affirm and a specimen for Aptima Combo 2 by the health care provider during the same office visit. Affirm was performed using the specific collection swab and the transport provided for the test. The ATV assay was performed on remnant Aptima Combo 2 specimens. A second ATV TMA assay, utilizing an alternate T. vaginalis primer and probe set, was performed on all specimens positive by the initial TMA and/or the Affirm assay. Infected-patient status was defined as positive T. vaginalis test results by at least 2 assays. Overall, 5.1% of subjects were positive for T. vaginalis. T. vaginalis was most prevalent in women who were 36 to 45 (11.9%), 51 to 60 (7.7%), and 16 to 25 (4.2%) years of age. The ATV assay was statistically more sensitive than the Affirm assay (100% versus 63.4%, P < 0.0001), identifying 36.6% more positive patients.
Department of Pathology, Rhode Island Hospital, Providence, RI 02903, USA.
Sarah B
SB
Andrea
Kimberle C
KC
Chapin
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D008875:Middle Aged; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D010274:Parasitology / Q000379:methods*; D011933:Reagent Kits, Diagnostic; D012680:Sensitivity and Specificity; D014247:Trichomonas Vaginitis / Q000175:diagnosis* / Q000469:parasitology; D014246:Trichomonas vaginalis / Q000302:isolation & purification*; D055815:Young Adult
D011933:Reagent Kits, Diagnostic
Sex Transm Dis. 1997 Jul;24(6):353-60
9243743
J Clin Microbiol. 2008 Oct;46(10):3368-74
18753347
Diagn Microbiol Infect Dis. 2010 Sep;68(1):66-72
20727473
J Clin Microbiol. 2000 Oct;38(10):3585-8
11015368
J Natl Cancer Inst. 2009 Oct 21;101(20):1406-11
19741211
Sex Transm Dis. 2010 Mar;37(3):165-8
20023598
J Clin Pathol. 2010 Mar;63(3):249-53
20203225
Clin Infect Dis. 2007 Jul 15;45(2):194-8
17578778
Am J Obstet Gynecol. 2009 Feb;200(2):188.e1-7
19185101
J Clin Microbiol. 2005 Feb;43(2):684-7
15695664
J Pediatr Adolesc Gynecol. 2010 Oct;23(5):312-6
20493735
Infect Dis Obstet Gynecol. 2000;8(5-6):248-57
11220487
J Clin Microbiol. 2009 Jan;47(1):59-63
18987174
J Clin Microbiol. 2004 Jul;42(7):3089-93
15243065
Clin Obstet Gynecol. 1993 Mar;36(1):137-44
8435938
Sex Transm Dis. 2008 Sep;35(9):797-800
18607317
Infect Dis Obstet Gynecol. 2004;12(1):17-21
15460191
Ann Clin Microbiol Antimicrob. 2006 Feb 17;5:4
16503990
J Clin Microbiol. 2008 Jun;46(6):2109-11
18400919
Sex Transm Dis. 2009 Jan;36(1):11-6
19008776
MedGenMed. 2005 Jun 21;7(2):61
16369439
Ann Epidemiol. 2009 Dec;19(12):891-9
19944351
Infect Dis Obstet Gynecol. 2005 Sep;13(3):145-50
16126499
J Clin Microbiol. 2006 Nov;44(11):4197-9
16943353
Am J Obstet Gynecol. 2004 Jan;190(1):281-90
14749674
J Clin Microbiol. 2006 Nov;44(11):3994-9
16971646